Extended-spectrum β-Lactamase Acquisition in Patients Receiving Systemic Cephalosporin Treatment for Salmonella spp. and Shigella spp. Infection

Clin Infect Dis. 2020 Feb 3;70(4):714-716. doi: 10.1093/cid/ciz468.

Authors

Barbara Spellerberg¹, Wolfgang Rabsch², Michael Pietsch³, Christian Denzer⁴, Carsten Posovszky⁴, Andreas Essig¹, Yvonne Pfeifer³

Affiliations

¹ Institute of Medical Microbiology and Hygiene, University Hospital Ulm.
² Fachgebiet (FG)11 National Reference Centre for Salmonella and Other Bacterial Enterics.
³ FG13 Nosocomial Pathogens and Antibiotic Resistance, Robert Koch Institute, Wernigerode.
⁴ Department of Paediatrics and Adolescent Medicine, University Hospital Ulm, Germany.

PMID: 31165140
DOI: 10.1093/cid/ciz468

No abstract available

Keywords: CTX-M; SHV; antibiotic resistance gastroenteritis; conjugation; enteric pathogens; plasmid transfer.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / therapeutic use
Cephalosporins* / therapeutic use
Humans
Microbial Sensitivity Tests
Plasmids
Salmonella / genetics
Shigella*
beta-Lactamases / genetics
beta-Lactams

Substances

Anti-Bacterial Agents
Cephalosporins
beta-Lactams
beta-Lactamases